Clinical Trial &  PipeLine

  • Home 
  • > Technology > 
  • Clinical Trial & PipeLine

Ongoing clinical trial

Project Name Principal Investigator
(Medical Center)
Status
1. Evaluation of biomarkers as predictors of response to sorafenib treatment in patients with hepaocellular carcinoma Dr. Wang
(Ajou University medical center)
11 clinical sites
Aimed no. of patients: 400
Current enrollment: 91
2. The Single-arm, Biomarker stratified, Prospective, Double-blinded, Multicenter Clinical Trial to Assess the Efficacy and the Safety of Combination Therapy of Hepatic Arterial Infusion of Cisplatin and 5-fluorouracil in Advanced Hepatocellular Carcinoma with Low Expression of HMGB2 Biomarker Dr. Bae
(The catholic University Seoul medical center)
11 clinical sites
Aimed no. of patients: 96
Current status: under review by IRBs
3. Validation of OncoHepaTest in Japan HCC patients Dr. Ueno
(Wakayama University medical center)
1 site
Aimed no. of patients: 200
Current enrollment: 80

Pipe Line

Dx PIPELINE

DRUG PIPELINE